Financial Data and Key Metrics Changes - In 2024, the company achieved record revenue of $1,170,000,000 and nearly $200,000,000 in adjusted EBITDA, indicating strong financial performance [4][5] - The company reported the lowest number of absolute client losses since 2021, maintaining a commitment from over 99% of its clients for 2025 [5] Business Line Data and Key Metrics Changes - The company added 1,100,000 new covered lives in 2024, marking the fourth consecutive year of adding at least 1,000,000 lives [5] - The launch of new solutions in maternity, postpartum, and menopause saw adoption rates of 20% among existing clients and 40% among new clients, reaching over 1,500,000 lives [6][7] Market Data and Key Metrics Changes - The company expanded its member base to 6,700,000 in 2025, nearly five times its size compared to five years ago [5] - The company successfully competed for jumbo accounts, winning every opportunity that came to a decision in the past year [5] Company Strategy and Development Direction - The company is following a multiyear product roadmap to expand its platform and address gaps in women's health and family health [6] - In 2025, the focus will be on enhancing solutions with a comprehensive set of digital tools for a best-in-class experience [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning for further success through channel partnerships and an expanded product portfolio [9] - The company plans to integrate recent acquisitions to fully realize their value and enhance user experience [9] Other Important Information - The company completed its first acquisitions that complement existing solutions and align with its long-term product roadmap [7] - The company is excited about launching LASIGNA as its first national health plan partner, adding to its ecosystem of large regional health plans [9] Q&A Session Summary - There were no questions from stockholders during the Q&A session, and the meeting was adjourned [21]
Progyny(PGNY) - 2025 FY - Earnings Call Transcript